国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
INTERNATIONAL JOURNAL OF ANESTHESIOLOGY AND RESUSCITATION
2013年
3期
216-219
,共4页
武丽娜%余剑波%宫丽荣%李莉%曹新顺%王曼%刘大全
武麗娜%餘劍波%宮麗榮%李莉%曹新順%王曼%劉大全
무려나%여검파%궁려영%리리%조신순%왕만%류대전
细胞外信号调节激酶1/2%内毒素休克%肺脏%血红素氧合酶-1
細胞外信號調節激酶1/2%內毒素休剋%肺髒%血紅素氧閤酶-1
세포외신호조절격매1/2%내독소휴극%폐장%혈홍소양합매-1
Extracellular signal-regulated kinases%Endotoxic shock%Lung%Heme oxygenase-1
目的 探讨细胞外信号调节激酶1/2(extracellular signal-regulated kinases,ERK1/2)通路在内毒素休克大鼠肺脏内血红素氧合酶-1 (heme oxygenase-1,HO-1)表达过程中作用. 方法 清洁级雄性SD大鼠48只,体重180 g~200 g,采用随机数字表法,随机分为4组(每组12只):假手术组(S组)、内毒素休克组(SS组)、内毒素休克+阻断剂组(SE组)和阻断剂组(E组).S组和SS组股静脉输注0.1ml二甲亚砜(DMSO),SE组和E组股静脉ERK1/2阻断剂PD98059 10 μmol/kg(溶于0.1 mlDMSO);30 min后,S组和E组分别给予0.5 ml生理盐水,SS组和SE组分别给予脂多糖(lipopolysaccharide,LPS) 10 mg/kg(溶于0.5 ml生理盐水),连续监测平均动脉压(mean arterial pressure,MAP),2h内SS组和SE组MAP下降≥基础血压25%,认为模型制备成功.根据病理学切片、超氧化物歧化酶(superoxide dismutase,SOD)活性及丙二醛(malondialdehyde,MDA)含量评定肺损伤程度,应用荧光定量PCR技术和Western blot技术测定ERK1/2和HO-1的表达,判断ERK1/2通路在内毒素休克大鼠肺脏HO-1表达过程中的作用. 结果 SS组的病理学评分(4.5±2.1)、肺含水率(81±6)%、MDA含量(3.12±1.30) nmol/mg明显高于S组(2.0±1.0)、(78±5)%、(1.79±0.12) nmol/mg和E组(2.1±1.1)、(77±4)%、(1.83±0.20) nmol/mg(P<0.05),但低于SE组(6.4±1.3)、(87±5)%、(4.62±0.92) nmol/mg(P<0.05);SS组SOD活性(20.2±2.4)NU/mg明显低于S组(30.9±2.9)NU/mg和E组(32.2±1.2) NU/mg(P<0.05),但高于SE组(14.9±3.2) NU/mg (P<0.05);SS组ERK1/2蛋白(0.43 ±0.09)及p-ERK1/2蛋白(1.46±0.22)、HO-1mRNA(1.834±0.023)及HO-1蛋白(1.17±0.25)表达明显高于SE组、S组和E组(P<0.05);上述指标在S组和E组之间差异无统计学意义(P>0.05). 结论 内毒素休克大鼠给予ERK1/2通路的阻断剂后,肺损伤加重,其机制可能与ERK 1/2被阻断后HO-1表达减少有关.
目的 探討細胞外信號調節激酶1/2(extracellular signal-regulated kinases,ERK1/2)通路在內毒素休剋大鼠肺髒內血紅素氧閤酶-1 (heme oxygenase-1,HO-1)錶達過程中作用. 方法 清潔級雄性SD大鼠48隻,體重180 g~200 g,採用隨機數字錶法,隨機分為4組(每組12隻):假手術組(S組)、內毒素休剋組(SS組)、內毒素休剋+阻斷劑組(SE組)和阻斷劑組(E組).S組和SS組股靜脈輸註0.1ml二甲亞砜(DMSO),SE組和E組股靜脈ERK1/2阻斷劑PD98059 10 μmol/kg(溶于0.1 mlDMSO);30 min後,S組和E組分彆給予0.5 ml生理鹽水,SS組和SE組分彆給予脂多糖(lipopolysaccharide,LPS) 10 mg/kg(溶于0.5 ml生理鹽水),連續鑑測平均動脈壓(mean arterial pressure,MAP),2h內SS組和SE組MAP下降≥基礎血壓25%,認為模型製備成功.根據病理學切片、超氧化物歧化酶(superoxide dismutase,SOD)活性及丙二醛(malondialdehyde,MDA)含量評定肺損傷程度,應用熒光定量PCR技術和Western blot技術測定ERK1/2和HO-1的錶達,判斷ERK1/2通路在內毒素休剋大鼠肺髒HO-1錶達過程中的作用. 結果 SS組的病理學評分(4.5±2.1)、肺含水率(81±6)%、MDA含量(3.12±1.30) nmol/mg明顯高于S組(2.0±1.0)、(78±5)%、(1.79±0.12) nmol/mg和E組(2.1±1.1)、(77±4)%、(1.83±0.20) nmol/mg(P<0.05),但低于SE組(6.4±1.3)、(87±5)%、(4.62±0.92) nmol/mg(P<0.05);SS組SOD活性(20.2±2.4)NU/mg明顯低于S組(30.9±2.9)NU/mg和E組(32.2±1.2) NU/mg(P<0.05),但高于SE組(14.9±3.2) NU/mg (P<0.05);SS組ERK1/2蛋白(0.43 ±0.09)及p-ERK1/2蛋白(1.46±0.22)、HO-1mRNA(1.834±0.023)及HO-1蛋白(1.17±0.25)錶達明顯高于SE組、S組和E組(P<0.05);上述指標在S組和E組之間差異無統計學意義(P>0.05). 結論 內毒素休剋大鼠給予ERK1/2通路的阻斷劑後,肺損傷加重,其機製可能與ERK 1/2被阻斷後HO-1錶達減少有關.
목적 탐토세포외신호조절격매1/2(extracellular signal-regulated kinases,ERK1/2)통로재내독소휴극대서폐장내혈홍소양합매-1 (heme oxygenase-1,HO-1)표체과정중작용. 방법 청길급웅성SD대서48지,체중180 g~200 g,채용수궤수자표법,수궤분위4조(매조12지):가수술조(S조)、내독소휴극조(SS조)、내독소휴극+조단제조(SE조)화조단제조(E조).S조화SS조고정맥수주0.1ml이갑아풍(DMSO),SE조화E조고정맥ERK1/2조단제PD98059 10 μmol/kg(용우0.1 mlDMSO);30 min후,S조화E조분별급여0.5 ml생리염수,SS조화SE조분별급여지다당(lipopolysaccharide,LPS) 10 mg/kg(용우0.5 ml생리염수),련속감측평균동맥압(mean arterial pressure,MAP),2h내SS조화SE조MAP하강≥기출혈압25%,인위모형제비성공.근거병이학절편、초양화물기화매(superoxide dismutase,SOD)활성급병이철(malondialdehyde,MDA)함량평정폐손상정도,응용형광정량PCR기술화Western blot기술측정ERK1/2화HO-1적표체,판단ERK1/2통로재내독소휴극대서폐장HO-1표체과정중적작용. 결과 SS조적병이학평분(4.5±2.1)、폐함수솔(81±6)%、MDA함량(3.12±1.30) nmol/mg명현고우S조(2.0±1.0)、(78±5)%、(1.79±0.12) nmol/mg화E조(2.1±1.1)、(77±4)%、(1.83±0.20) nmol/mg(P<0.05),단저우SE조(6.4±1.3)、(87±5)%、(4.62±0.92) nmol/mg(P<0.05);SS조SOD활성(20.2±2.4)NU/mg명현저우S조(30.9±2.9)NU/mg화E조(32.2±1.2) NU/mg(P<0.05),단고우SE조(14.9±3.2) NU/mg (P<0.05);SS조ERK1/2단백(0.43 ±0.09)급p-ERK1/2단백(1.46±0.22)、HO-1mRNA(1.834±0.023)급HO-1단백(1.17±0.25)표체명현고우SE조、S조화E조(P<0.05);상술지표재S조화E조지간차이무통계학의의(P>0.05). 결론 내독소휴극대서급여ERK1/2통로적조단제후,폐손상가중,기궤제가능여ERK 1/2피조단후HO-1표체감소유관.
Objective To investigate the effects of extracellular signal-regulated kinases (ERK1/2) signaling pathway on the expression of heme oxygenase-1 (HO-1) in acute lung injury of endotoxic shock induced by lipopolysaccharide (LPS) in rats.Methods Forty-eight pathogen-free male SD rats weighing 180 g-200 g were randomly divided into 4 groups (n=12 each):sham operation group (group S),endotoxic shock group (group SS),endotoxic shock and PD98059 group (group SE) and PD98059 group (group E).Rats in group S and group SS were administrated with DMSO 0.1 ml intravenously.Rats in Group SE and group E were injected with the inhibitor of ERK1/2 (PD98059) in 0.1 ml DMSO intravenously.30 min later,rats in Group S and group E received 0.5 ml normal saline intravenously while rats in group SS and group SE received LPS 10 mg/kg in 0.5 ml normal saline intravenously.The invasive arterial pressure was monitored,if there was an initial 25% decrease in mean arterial pressure,then the model can be put to use.The lung injury degree was judged by microscopic examination,moisture content,malondialdehyde (MDA) content and superoxide dismutase (SOD) activity.The ERK1/2 protein,p-ERK1/2 protein and HO-1 protein were measured by Western blot.HO-1 mRNA level were measured by RT-PCR.Results The grade of the pathology (4.5 ±2.1),MDA content (3.12±1.30) nmol/mg,moisture content(81±6)% in group SS were significantly higher than that in group S (2.0±1.0),(78±5)%,(1.79±0.12) nmol/mgand group E (2.1±1.1),(77±4)%,(1.83±-0.20) nmol/mg,(P<0.05).But significantly lower than that in group SE(6.4±1.3),(87±5)%,(4.62±0.92) nmol/mg (P<0.05).The SOD activity in group SS (20.2±2.4) NU/mg were significantly lower than that in group S (30.9± 2.9) NU/mgand group E (32.2±1.2) NU/mg(P<0.05),but significantly higher than that in group SE(14.9±3.2) NU/mg(P<0.05).ERK1/2 protein (0.43±0.09) and p-ERK1/2 protein (1.46 ±0.22),HO-1mRNA (1.834± 0.023) and HO-1 protein (1.17± 0.25) in group SS were significantly higher than that in group S,group SE and group E (P<0.05).And there were no significant difference in group S and group P among all the indexes (P>0.05).Conclusions Using the inhibitor of ERK1/2 signaling pathway in endotoxic shock rats worsened lung injury,and its mechanism may be related to decreased HO-1 expression by inhibition of ERK1/2 signaling pathway.